Ask AI
ProCE Banner Activity

Optimizing Modern HAE Management With Novel Therapies and Patient-Centered Care

Clinical Thought

Learn how the treatment landscape for hereditary angioedema (HAE) is evolving as novel long-term prophylaxis therapies emerge, and attain take-home strategies to improve your practice in providing individualized care that optimizes treatment for patients with HAE.

Released: August 27, 2025

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Marc Riedl, MD, MS: consultant/advisor/speaker: Astria, BioCryst, BioMarin, Celldex, CSL Behring, Cycle Pharma, Grifols, Intellia, Ionis, Kalvista, Novartis, Pharming, Pharvaris, Sanofi/Regeneron, Takeda; researcher: Astrai, BioCryst, BioMarin, CSL Behring, Intellia, Ionis, Kalvista, Pharvaris, Takeda.